京新药业(002020.SZ)递交H股发行上市申请

Core Viewpoint - The company, Jingxin Pharmaceutical (002020.SZ), has submitted an application for the issuance of overseas listed shares (H shares) and for listing on the main board of the Hong Kong Stock Exchange on February 11, 2026 [1] Group 1 - The application materials for this issuance and listing have been published on the Hong Kong Stock Exchange website on the same day [1]